1. Identify disease modifying therapies in sickle cell disease
  2. Demonstrate knowledge of how to use currently available treatments
  3. Summerize the factors that contribute to the heterogeneity in VTE risk among cancer patients
  4. Outline the evolving role of the direct oral anticoagulants in treating cancer associated thrombosis


Event address for attendees: https://uwmadison.webex.com/uwmadison/onstage/g.php?MTID=e6e900959d4bd98606809a6144c0ee9fd

Session date: 
02/24/2021 - 8:00am to 9:00am CST
Clinical Science Center, G5/119
600 Highland Ave
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Dr. John Sheehan
Dr. Moniba Nazeef